Immunotherapy for Lung Cancer

Immunotherapy for Lung Cancer: How It’s Changing the Future of Cancer Treatment

Immunotherapy for lung cancer is revolutionizing how physicians address this severe illness. Rather than targeting cancer directly, it enhances your immune system’s ability to naturally locate and eliminate cancer cells.

In this blog, we’ll explore how immunotherapy works, its types, cost in India, benefits, side effects, and success rate — helping you understand why it’s considered the future of lung cancer treatment.

What Is Immunotherapy for Lung Cancer?

Immunotherapy is a contemporary cancer therapy that utilizes your body’s inherent defense mechanisms to combat cancer.

Cancer cells frequently conceal themselves from the immune system by producing proteins that prevent immune cells from detecting them. Immunotherapy drugs inhibit these signals, enabling your body to recognize and effectively combat cancer.

Doctors recommend immunotherapy for:

  • Non-small cell lung cancer (NSCLC) — the most common type

  • Advanced or metastatic lung cancer

  • Patients whose cancer has returned after chemotherapy

  • Those not responding well to traditional treatments

 

Types of Immunotherapy for Lung Cancer

Various immunotherapy options for lung cancer exist, tailored to the patient’s health, type of cancer, and stage.

Type of Immunotherapy

Description

Common Drugs

Immune Checkpoint Inhibitors

Block the proteins that stop the immune system from attacking cancer cells

Pembrolizumab (Keytruda), Nivolumab (Opdivo), Atezolizumab (Tecentriq)

Monoclonal Antibodies

Lab-made proteins that attach to cancer cells and mark them for destruction

Bevacizumab (Avastin)

Cancer Vaccines

Train the immune system to recognize and fight specific cancer cells

CIMAvax-EGF

Adoptive T-cell Therapy

Strengthens the patient’s immune cells before re-injecting them

Under clinical trials

Note: The choice of immunotherapy depends on the cancer type, genetic testing, and patient health.

How Immunotherapy Works – Step by Step

Immunotherapy for lung cancer helps the body’s own immune cells attack tumors. Here’s how it works:

  1. Cancer Identification: Physicians conduct genetic and biomarker assessments to determine if your cancer will react to immunotherapy.

  2. Drug Administration: Medications are administered via IV (intravenous drip) in cycles—typically every 2–3 weeks.

  3. Immune Activation: The medications assist the immune system in identifying and targeting lung cancer cells.

  4. Monitoring & Response: Physicians continuously assess tumor dimensions and patient reactions using imaging tests.

  5. Maintenance Therapy: If the treatment is effective, maintenance cycles are continued for long-term control.

When Is Immunotherapy Recommended?

Immunotherapy is typically suggested when:

  • Lung cancer has disseminated to different areas of the body (metastatic).
  • Conventional therapies such as chemotherapy or radiation have not been effective.
  • The tumor in the patient displays distinct markers such as PD-L1 or EGFR mutations.
  • The patient’s general health permits immune-based treatment.

Doctors customize treatment plans following the analysis of your blood and tumor samples to determine if immunotherapy is appropriate for you.

Immunotherapy for Lung Cancer
Immunotherapy for Lung Cancer

Benefits of Immunotherapy for Lung Cancer

Immunotherapy has proven to be a revolutionary treatment with several long-term benefits for lung cancer patients.

Key Benefits Include:

  • Targets only cancer cells, reducing harm to healthy tissues.

  • Delivers enduring effects through immune system training.

  • Enhances survival rates in advanced lung cancer.

  • Reduced side effects in comparison to chemotherapy.

  • Improves life quality and enables patients to maintain regular activities.

Cost of Immunotherapy for Lung Cancer in India

The expense of immunotherapy in India varies based on the hospital, type of medication, and the required number of cycles. Since immunotherapy drugs are advanced biological medicines, they tend to be more expensive than traditional treatments.

Type of Immunotherapy

Minimum Cost (₹)

Average Cost (₹)

Maximum Cost (₹)

Checkpoint Inhibitors

₹1,50,000

₹2,50,000

₹3,50,000 per cycle

Monoclonal Antibody Therapy

₹1,20,000

₹2,00,000

₹3,00,000 per cycle

Cancer Vaccines (Trial-based)

₹80,000

₹1,50,000

₹2,50,000 per dose

Note: Total cost depends on the number of cycles prescribed and the hospital location. 

Side Effects of Immunotherapy

While immunotherapy for lung cancer is generally well-tolerated, it may cause mild-to-moderate side effects as the immune system becomes more active.

Common Side Effects Include:

  • Fatigue or weakness

  • Skin rash or itching

  • Fever, chills, or cough

  • Shortness of breath

  • Diarrhea or nausea

  • Mild inflammation in lungs or liver (rare)

Most side effects are temporary and can be managed with medication and monitoring.

Immunotherapy vs. Chemotherapy for Lung Cancer

Aspect

Immunotherapy

Chemotherapy

How it Works

Boosts the immune system to destroy cancer cells

Uses strong drugs to kill cancer cells directly

Side Effects

Mild and manageable

Hair loss, nausea, fatigue

Effectiveness

Long-term and targeted

Short-term and less specific

Quality of Life

Better during treatment

Often affected by strong side effects

Duration

Works gradually but can have lasting effects

Quick action but shorter results

Immunotherapy Success Rate in Lung Cancer

The effectiveness of immunotherapy for lung cancer has notably increased in recent years.

Clinical research indicates a 60–70% enhancement in survival rates for patients who react positively to this therapy.

Patients have reported:

  • Reduced tumor size

  • Longer remission periods

  • Better breathing and energy levels

  • Improved long-term health outcomes

Through ongoing studies and progressive treatments, immunotherapy provides genuine promise for sustained lung cancer management.

Factors Affecting Immunotherapy Results

Major factors include:

  • Cancer stage and spread at diagnosis

  • Type of lung cancer (NSCLC or SCLC)

  • Patient’s immune strength and overall health

  • Presence of biomarkers like PD-L1

  • Lifestyle and nutrition during treatment

Doctors personalize treatment for every patient based on these factors to maximize results.

When to Consult a Cancer Specialist

You should consult an oncologist or lung cancer specialist if:

  • You have a persistent cough or chest pain.

  • Breathing difficulties or unexplained fatigue occur.

  • You’ve been diagnosed with advanced or recurring lung cancer.

  • Chemotherapy and radiation are not proving to be effective.

Early consultation helps determine if immunotherapy is the right choice for your condition.

Towards Better Healing and Health

Immunotherapy for lung cancer has opened a new era in cancer care. By helping your immune system recognize and fight cancer cells, it offers safer, long-lasting, and more personalized treatment.
With rising success rates and fewer side effects, immunotherapy is giving new hope to lung cancer patients across India and the world.
Consult your oncologist to know if immunotherapy is right for you and take the next step toward a healthier, cancer-free future.

FAQs About Immunotherapy for Lung Cancer

How long does immunotherapy take to show results?

Most patients start noticing improvements within 2–3 months, though response time varies.

Can immunotherapy cure lung cancer completely?

While it may not cure all cases, it can control cancer growth and extend survival for many patients.

Is immunotherapy painful?

No, it’s usually given through an IV drip and is painless, similar to chemotherapy infusions.

How many cycles are required?

Typically, patients receive immunotherapy every 2–3 weeks for several months, depending on the treatment plan.

Is immunotherapy available in India?

Yes, immunotherapy is available in top cancer hospitals across India and is increasingly accessible for patients nationwide.